Once- or twice-daily thoracic radiation in limited-stage small-cell lung cancer treated with concurrent chemoradiotherapy.

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2025-09-25 DOI:10.1002/14651858.CD016084

Ken Harada, Kazuya Inoki, Takenori Ichimura, Kanae Taruno, Hidenori Shinjo, Noyuri Yamaji, Hisashi Noma, Erika Ota, Takeshi Hasegawa

引用次数: 0

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of once-daily radiotherapy versus twice-daily radiotherapy concurrently with chemotherapy for optimal survival outcomes in people with limited-stage small-cell lung cancer (LS-SCLC).

查看原文本刊更多论文

同步放化疗治疗的有限期小细胞肺癌患者每日一次或两次胸部放射治疗。

目的：这是Cochrane综述（干预）的一个方案。目的如下：评估每日一次放疗与每日两次放疗并化疗对有限期小细胞肺癌（LS-SCLC）患者最佳生存结果的利弊。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.